Reducing inappropriate antibiotic prescribing will improve the quality of patient care, decrease healthcare costs, and preserve the effectiveness of antibiotics.
Daliresp is a selective phosphodiesterase 4 inhibitor that reduces risk for chronic obstructive pulmonary disease exacerbations in severely effected patients with COPD that have chronic bronchitis and a history of exacerbations.
I see a number of non-asthmatic patients who use the corticosteroid/beta agonist combination fluticasone/salmeterol (Advair) on an as-needed basis for symptoms of uncomplicated acute viral bronchitis. Is there any validity to this use? Advair is also prescribed frequently for mild persistent asthma in lieu of an inhaled steroid. Am I off base in questioning this…
